Revenues grew 4.1% YoY to | 217.5 crore (I-direct estimate: | 277.1 crore). The 50.1% YoY growth in domestic formulations to | 149.7 crore (I-direct estimate: | 159.5 crore), led by lower base of GST impact in Q1FY18, was largely offset by 51.8% YoY decline in export formulations to | 41.4 crore (I-direct estimate: | 88.3 crore) EBITDA margins rose 470 bps YoY to 5.3% but lower than I-direct estimate of 15.8% mainly due to poor export formulations revenues Net loss fell 44.7% YoY to | 12.0 crore (I-direct net profit estimate:...